Skip to main content
Erschienen in: Supportive Care in Cancer 3/2015

01.03.2015 | Original Article

Patient-Generated Subjective Global Assessment in relation to site, stage of the illness, reason for hospital admission, and mortality in patients with gynecological tumors

verfasst von: Camila Santos Rodrigues, Gabriela Villaça Chaves

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to identify factors related to the illness and to oncological treatment as determinants of the nutritional status of patients with gynecological tumors.

Methods

This is a retrospective study; the group was composed of 146 women histopathologically shown to have gynecological tumors, at different stages of treatment, and hospitalized at the foremost centers for the prevention and treatment of cancer in Rio de Janeiro. To obtain a nutritional diagnosis, we used the Patient-Generated Subjective Global Assessment (PG-SGA). We did multiple comparisons of the numeric variables between the three PG-SGA nutritional status-classification groups by performing Kruskal-Wallis analysis of variance. We used the Mann-Whitney test to compare numerical variables between two groups. We analyzed the associations between categorical variables by using either the chi-squared (χ 2) test or Fisher’s exact test.

Results

Of the women, 62.4 % were found to be at nutritional risk or to have some level of malnourishment, being more associated with the reason for hospital admission and stage disease that properly to the tumor site. The median PG-SGA score was points, with 62.3 % of the group returning 9 or more points. Women diagnosed with endometrial cancer were found to be predominantly well nourished, and those with tumors in the ovary were more frequently diagnosed as being severely malnourished.

Conclusions

Our findings support early nutritional intervention in the population identified as being at greater nutritional risk, aiming to minimize the loss of muscle mass and body weight, as well as to improve symptoms management, thus helping to achieve better clinical results.
Literatur
1.
Zurück zum Zitat Peres GB, Valim GS, Silva VL, El-Kik RM (2009) Comparação entre métodos de Avaliação Subjetiva Global em oncologia. Rev Ciênc Saúde 2:37–42 Peres GB, Valim GS, Silva VL, El-Kik RM (2009) Comparação entre métodos de Avaliação Subjetiva Global em oncologia. Rev Ciênc Saúde 2:37–42
2.
Zurück zum Zitat Laky B, Janda M, Kondalsamy-Channakesavan S et al (2010) Pretreatment malnutrition and quality of life-association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study. BMC Cancer. doi:10.1186/1471-2407-10-232 PubMedCentralPubMed Laky B, Janda M, Kondalsamy-Channakesavan S et al (2010) Pretreatment malnutrition and quality of life-association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study. BMC Cancer. doi:10.​1186/​1471-2407-10-232 PubMedCentralPubMed
3.
Zurück zum Zitat Ottery FD (1996) Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 12:15–19CrossRef Ottery FD (1996) Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 12:15–19CrossRef
4.
Zurück zum Zitat Davies M (2005) Nutritional screening and assessment in cancer-associated malnutrition. Eur J Oncol Nurs 9:64–73CrossRef Davies M (2005) Nutritional screening and assessment in cancer-associated malnutrition. Eur J Oncol Nurs 9:64–73CrossRef
5.
Zurück zum Zitat Laky B, Janda M, Cleghorn G et al (2008) Comparison of different nutritional assessments and body composition measurements in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr 87:1678–1685PubMed Laky B, Janda M, Cleghorn G et al (2008) Comparison of different nutritional assessments and body composition measurements in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr 87:1678–1685PubMed
6.
Zurück zum Zitat Laky B, Janda M, Bauer J et al (2007) Malnutrition among gynaecological cancer patients. Eur J Clin Nutr 61:642–646PubMed Laky B, Janda M, Bauer J et al (2007) Malnutrition among gynaecological cancer patients. Eur J Clin Nutr 61:642–646PubMed
7.
Zurück zum Zitat Ottery FD (2000) Patient-Generated Subjective Global Assessment. In: The clinical guide to oncology nutrition. Am Diet Assoc 11–23 Ottery FD (2000) Patient-Generated Subjective Global Assessment. In: The clinical guide to oncology nutrition. Am Diet Assoc 11–23
8.
Zurück zum Zitat Gonzalez MC, Borges LR, Silveira DH, Assunção MCF, Orlandi SP (2010) Validação da versão em português da avaliação subjetiva global produzida pelo paciente. Rev Bras Nutr Clin 25:102–108 Gonzalez MC, Borges LR, Silveira DH, Assunção MCF, Orlandi SP (2010) Validação da versão em português da avaliação subjetiva global produzida pelo paciente. Rev Bras Nutr Clin 25:102–108
9.
Zurück zum Zitat Pecotelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet 105:103–104CrossRef Pecotelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet 105:103–104CrossRef
10.
Zurück zum Zitat Santoso JT, Canada T, Latson B et al (2000) Prognostic nutritional index in relation to hospital stay in women with gynecologic cancer. Obstet Gynecol 95:844–846PubMedCrossRef Santoso JT, Canada T, Latson B et al (2000) Prognostic nutritional index in relation to hospital stay in women with gynecologic cancer. Obstet Gynecol 95:844–846PubMedCrossRef
11.
Zurück zum Zitat Bozzetti F, Migliavacca S, Scotti A (1982) Impact of cancer, type, site, stage and treatment on the nutritional status of patients. Ann Surg 196:170–174PubMedCentralPubMedCrossRef Bozzetti F, Migliavacca S, Scotti A (1982) Impact of cancer, type, site, stage and treatment on the nutritional status of patients. Ann Surg 196:170–174PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Tunca JC (1983) Nutritional evaluation of gynecologic cancer patients during initial diagnosis of their disease. Am J Obstet Gynecol 147:893–896PubMed Tunca JC (1983) Nutritional evaluation of gynecologic cancer patients during initial diagnosis of their disease. Am J Obstet Gynecol 147:893–896PubMed
13.
Zurück zum Zitat Zorlini AR, Cairo AA, Gurgel MS (2008) Nutritional status of patients with gynecologic and breast cancer. Nutr Hosp 23:577–583PubMed Zorlini AR, Cairo AA, Gurgel MS (2008) Nutritional status of patients with gynecologic and breast cancer. Nutr Hosp 23:577–583PubMed
15.
Zurück zum Zitat Herrinton LJ, Neslund-Dudas C, Rolnick SJ et al (2007) Complications at the end of life in ovarian cancer. J Pain Symptom Manage 34:237–243PubMedCrossRef Herrinton LJ, Neslund-Dudas C, Rolnick SJ et al (2007) Complications at the end of life in ovarian cancer. J Pain Symptom Manage 34:237–243PubMedCrossRef
17.
Zurück zum Zitat Schmandt RE, Iglesias DA, Co NN et al (2011) Understanding obesity and endometrial cancer risk: opportunities for prevention. Am J Obstet Gynecol 205:518–525PubMedCentralPubMedCrossRef Schmandt RE, Iglesias DA, Co NN et al (2011) Understanding obesity and endometrial cancer risk: opportunities for prevention. Am J Obstet Gynecol 205:518–525PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Leslie KK (2012) Endometrial cancer. Obstet Gynecol Clin N Am 39:255–268CrossRef Leslie KK (2012) Endometrial cancer. Obstet Gynecol Clin N Am 39:255–268CrossRef
19.
Zurück zum Zitat Shadad AK, Sullivan FJ, Martin JD, Egan LJ (2013) Gastrointestinal radiation injury: prevention and treatment. World J Gastroenterol 19:199–208PubMedCentralPubMedCrossRef Shadad AK, Sullivan FJ, Martin JD, Egan LJ (2013) Gastrointestinal radiation injury: prevention and treatment. World J Gastroenterol 19:199–208PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Calixto-Lima L, Martins de Andrade E, Gomes AP et al (2012) Dietetic management in gastrointestinal complications from antimalignant chemotherapy. Nutr Hosp 27:65–75PubMed Calixto-Lima L, Martins de Andrade E, Gomes AP et al (2012) Dietetic management in gastrointestinal complications from antimalignant chemotherapy. Nutr Hosp 27:65–75PubMed
21.
Zurück zum Zitat Blanchard CM, Denniston MM, Baker F et al (2003) Do adults change their lifestyle behaviours after a cancer diagnosis. Am J Health Behav 27:246–256PubMedCrossRef Blanchard CM, Denniston MM, Baker F et al (2003) Do adults change their lifestyle behaviours after a cancer diagnosis. Am J Health Behav 27:246–256PubMedCrossRef
22.
Zurück zum Zitat Eickmeyer SM, Gamble GL, Shahpar S (2012) The role and efficacy of exercise in persons with cancer. PMR 4:874–881CrossRef Eickmeyer SM, Gamble GL, Shahpar S (2012) The role and efficacy of exercise in persons with cancer. PMR 4:874–881CrossRef
23.
Zurück zum Zitat Raaf PJ, Klerk C, Timman R et al (2013) Systematic monitoring and treatment of physical symptoms to alleviate fatigue in patients with advanced cancer: a randomized controlled trial. J Clin Oncol 31:716–723PubMedCrossRef Raaf PJ, Klerk C, Timman R et al (2013) Systematic monitoring and treatment of physical symptoms to alleviate fatigue in patients with advanced cancer: a randomized controlled trial. J Clin Oncol 31:716–723PubMedCrossRef
24.
Zurück zum Zitat Caro MM, Laviano A, Pichard C (2007) Nutritional intervention and quality of life in adult oncology patients. Clin Nutr 26:289–301CrossRef Caro MM, Laviano A, Pichard C (2007) Nutritional intervention and quality of life in adult oncology patients. Clin Nutr 26:289–301CrossRef
26.
Zurück zum Zitat Bauer J, Capra S, Ferguson M (2002) Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56:779–785PubMedCrossRef Bauer J, Capra S, Ferguson M (2002) Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56:779–785PubMedCrossRef
27.
Zurück zum Zitat Pressoir M, Desné S, Berchery D et al (2010) Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer 102:966–971PubMedCentralPubMedCrossRef Pressoir M, Desné S, Berchery D et al (2010) Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer 102:966–971PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Barbosa-Silva MC, Barros AJD (2006) Indications and limitations of the use of subjective global assessment in clinical practice: an update. Curr Opin Clin Nutr Metab Care 9:263–269PubMedCrossRef Barbosa-Silva MC, Barros AJD (2006) Indications and limitations of the use of subjective global assessment in clinical practice: an update. Curr Opin Clin Nutr Metab Care 9:263–269PubMedCrossRef
29.
Zurück zum Zitat Norman K, Pichard C, Lochs H, Pirlich M (2008) Prognostic impact of disease-related malnutrition. Clin Nutr 27:5–15PubMedCrossRef Norman K, Pichard C, Lochs H, Pirlich M (2008) Prognostic impact of disease-related malnutrition. Clin Nutr 27:5–15PubMedCrossRef
Metadaten
Titel
Patient-Generated Subjective Global Assessment in relation to site, stage of the illness, reason for hospital admission, and mortality in patients with gynecological tumors
verfasst von
Camila Santos Rodrigues
Gabriela Villaça Chaves
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 3/2015
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2409-7

Weitere Artikel der Ausgabe 3/2015

Supportive Care in Cancer 3/2015 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.